Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

BioAge Labs, Inc. (BIOA) Institutional Ownership & Insider Trading

151 institutions reported holding BioAge Labs, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 13 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BIOABioAge Labs, Inc.Follow BIOA — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
234.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

151 institutions held 82.2% of the shares. Across filers that reported both quarters, shares held changed +9.1%.

Increased+57New+26Decreased-40Closed-17

Largest moves, shares (millions)

Mpm Bioimpact+1.7MBlackRock+0.6MNuveen+0.3MBalyasny Asset Management-0.6MCormorant Asset Management-0.5MStempoint Capital-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24-1.2Dec 24+0.6Mar 25+0.6Jun 25+0.6Sep 25+3.1Dec 25+10.5Mar 26+3.0Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2615138+9.1%57264017
Mar 2614435+47.4%46422616
Dec 2511224+15.9%4023236
Sep 259221+2.8%3012183
Jun 258221+2.8%312496
Mar 256720+3.2%15141710
Dec 246320-5.7%1033929
Sep 245721—————

BioAge Labs, Inc. — questions

Who owns BioAge Labs, Inc. stock?
151 institutions reported BioAge Labs, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: a16z Capital Management, L.L.C. (7.0%), BlackRock, Inc. (6.2%), Cormorant Asset Management, LP (5.2%).
Are BioAge Labs, Inc. insiders buying or selling?
13 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from BioAge Labs, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.